semustine has been researched along with melphalan in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (60.00) | 18.7374 |
| 1990's | 2 (6.67) | 18.2507 |
| 2000's | 6 (20.00) | 29.6817 |
| 2010's | 3 (10.00) | 24.3611 |
| 2020's | 1 (3.33) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Berman, R; Bird, GG; Bunch, GA; Gajjar, PD; Giles, GR; Hall, R; Malhotra, A | 1 |
| DeVita, VT; Weiss, RB | 1 |
| Galin, M; Hill, GJ; Hill, HZ; Miller, CL; Pfaller, M; Weiss, K | 1 |
| DiBenedetto, J; Evans, JT; Mittelman, A; Moayeri, H | 1 |
| Barranco, SC; Beasley, EG; Jenkins, VK; MacLean, KK; Townsend, CM; Weintraub, B | 1 |
| Gantchev, GT; Getov, CM; Ilarionova, MV; Maneva, KM; Silyanovska, KK; Todorov, DK | 1 |
| Dhingra, K | 1 |
| Livnat, I; Perk, K; Zimber, A | 1 |
| Ozhiganov, EL; Platinskiĭ, LV; Sokolova, VD | 1 |
| Adams, K; Peacock, JH; Stephens, TC | 1 |
| Courtenay, VD; Mills, J; Steel, GG | 1 |
| Berman, R; Steel, GG | 1 |
| Lohrmann, HP | 1 |
| Curuchet, M; Dragosky, M; Garay, G; Huberman, AB; Lein, JM; Palmer, L; Pavlovsky, S; Quiroga-Micheo, E; Saslavsky, J; Tezanos Pinto, M | 1 |
| Osieka, R | 1 |
| Becherini, JO; Cavagnaro, F; Jait, C; Lein, JM; Micheo, EQ; Musso, A; Pavlovsky, S; Pileggi, JE; Pizzolato, M; Suárez, A | 1 |
| Selby, PJ; Steel, GG | 1 |
| Bateman, AE; Selby, PJ; Steel, GG; Towse, GD | 1 |
| Catane, R; Clement, JJ; Gorman, MS; Johnson, RK; Wodinsky, I | 1 |
| Deng, C; Jia, Y; Liu, T; Lu, Z; Meng, W; Wang, H; Wu, J; Yang, Y | 1 |
| Katai, H; Saka, M; Sano, T; Sasako, M | 1 |
| Fujiwara, Y; Monden, M; Mori, T; Takiguchi, S; Yano, M; Yasuda, T | 1 |
| Guo, Y; Han, X; Li, H; Lin, D; Miao, X; Shi, Y; Sun, T; Tan, W; Wang, L; Zhang, X; Zhao, D; Zhou, Y | 1 |
| Jia, YQ; Leng, YM; Liu, T; Lu, JC; Meng, WT; Niu, T; Wang, H; Xu, CG | 1 |
| Bremer, M; Karstens, JH; Meier Zu Eissen, J; Meyer, A | 1 |
| Angelini, V; Arcadipane, F; Bombaci, S; Cassoni, P; Franco, P; Migliaccio, F; Mistrangelo, M; Morino, M; Munoz, F; Numico, G; Racca, P; Ragona, R; Ricardi, U; Rondi, N; Sciacero, P; Spadi, R | 1 |
| Jeong, CW; Kang, M; Kim, HH; Ku, JH; Kwak, C | 1 |
| Chen, J; Huang, H; Jiang, Y; Jin, Z; Liu, S; Ruan, J; Wu, D; Xiao, X; Zhang, L; Zhang, X | 1 |
| Chen, X; Chu, J; Huang, H; Jiang, Y; Jin, Z; Li, C; Liu, S; Qian, C; Qu, C; Wu, D; Xu, T; Yang, H; Zhang, L; Zhang, X; Zhou, J; Zhu, Q | 1 |
4 review(s) available for semustine and melphalan
| Article | Year |
|---|---|
[Chemotherapy of cancer of the large intestine].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Colonic Neoplasms; Drug Evaluation; Fluorouracil; Humans; Lomustine; Melphalan; Methotrexate; Rectal Neoplasms; Semustine; Vincristine | 1985 |
The problem of permanent bone marrow damage after cytotoxic drug treatment.
Topics: Animals; Antineoplastic Agents; Bone Marrow Diseases; Busulfan; Carmustine; Cell Division; Cell Survival; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Hematopoiesis; Hematopoietic Stem Cells; Humans; Melphalan; Semustine; Time Factors | 1984 |
[Current status and problem of adjuvant chemotherapy for curatively resected gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Drug Administration Schedule; Fluorouracil; Gastrectomy; Humans; Melphalan; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Semustine; Stomach Neoplasms; Tegafur; Uracil | 2000 |
Single, immediate postoperative instillation of chemotherapy in non-muscle invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials using different drugs.
Topics: Administration, Intravesical; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cyclophosphamide; Doxorubicin; Epirubicin; Humans; Melphalan; Network Meta-Analysis; Semustine; Treatment Outcome; Urinary Bladder Neoplasms | 2016 |
6 trial(s) available for semustine and melphalan
| Article | Year |
|---|---|
Randomized trial of melphalan plus 5-fluorouracil (5-FU) versus methyl-CCNU plus 5-FU in patients with advanced colorectal cancer.
Topics: Adult; Aged; Clinical Trials as Topic; Colonic Neoplasms; Drug Therapy, Combination; Fluorouracil; Humans; Melphalan; Middle Aged; Nitrosourea Compounds; Rectal Neoplasms; Semustine | 1978 |
The dilemma regarding postoperative chemotherapy in primary carcinoma of the colon.
Topics: Antineoplastic Agents; BCG Vaccine; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Colonic Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Mycobacterium bovis; Neoplasm Metastasis; Postoperative Care; Semustine; Vincristine | 1979 |
Treatment of multiple myeloma: an Argentine Group for the Treatment of Acute Leukemia Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Argentina; Clinical Trials as Topic; Cyclophosphamide; Humans; Melphalan; Multiple Myeloma; Prednisone; Random Allocation; Semustine; Vincristine | 1988 |
A randomized trial of melphalan and prednisone versus melphalan, prednisone, cyclophosphamide, MeCCNU, and vincristine in untreated multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Proteins; Clinical Trials as Topic; Cyclophosphamide; Humans; Immunoglobulins; Melphalan; Multiple Myeloma; Myeloma Proteins; Neoplasm Staging; Prednisone; Random Allocation; Semustine; Time Factors; Vincristine | 1984 |
Comparison of two combination chemotherapy regimens for multiple myeloma: methyl-CCNU, cyclophosphamide, and prednisone versus melphalan and prednisone.
Topics: Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Humans; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Staging; Prednisone; Prognosis; Semustine; Time Factors | 1980 |
Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; Cyclophosphamide; Disease-Free Survival; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Male; Melphalan; Middle Aged; Proportional Hazards Models; Radiotherapy, Intensity-Modulated; Semustine | 2015 |
20 other study(ies) available for semustine and melphalan
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Effects of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide, 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea, and L-phenylalanine mustard on B16, Cloudman S91, and Harding-Passey mouse melanomas.
Topics: Animals; Cell Count; Dacarbazine; Female; Melanoma; Melphalan; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Neoplasms, Experimental; Nitrosourea Compounds; Semustine; Time Factors; Transplantation, Isogeneic; Triazenes | 1979 |
Phase II study of melphalan in colorectal carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Colonic Neoplasms; Drug Evaluation; Female; Fluorouracil; Humans; Male; Melphalan; Middle Aged; Neoplasm Metastasis; Prospective Studies; Rectal Neoplasms; Semustine | 1978 |
Relationship between glutathione levels and drug or radiation sensitivities in human gastric cancer cell lines in vitro.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Chlorambucil; Cyclophosphamide; Doxorubicin; Drug Resistance; Fluorouracil; Glutathione; Humans; Melphalan; Radiation Tolerance; Semustine; Stomach Neoplasms; Tumor Cells, Cultured | 1991 |
Chemo- and immunotherapy of an adenovirus-induced transplantable sarcoma in hamsters.
Topics: Adenoviridae Infections; Alkylating Agents; Animals; Antimetabolites; Cricetinae; Cyclophosphamide; Female; Fluorouracil; Immunotherapy; Male; Melphalan; Mercaptopurine; Mesocricetus; Methotrexate; Mycobacterium bovis; Neoplasm Transplantation; Sarcoma, Experimental; Semustine | 1987 |
Priming with low doses of methyl-CCNU reduce the toxicity of high doses of methyl-CCNU and melphalan, and increase the lifespan of mice implanted with Lewis lung carcinoma.
Topics: Animals; Lung Neoplasms; Male; Melphalan; Mice; Mice, Inbred C57BL; Nitrosourea Compounds; Semustine | 1988 |
Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo.
Topics: Animals; Carmustine; Cell Line; Cell Survival; Cisplatin; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Resistance; Lomustine; Lung Neoplasms; Melphalan; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Nitrosourea Compounds; Semustine; Time Factors | 1986 |
The spectrum of chemosensitivity of two human pancreatic carcinoma xenografts.
Topics: Altretamine; Animals; Antineoplastic Agents; Cell Line; Cisplatin; Cyclophosphamide; Hindlimb; Humans; Melphalan; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Pancreatic Neoplasms; Semustine; Streptozocin; Transplantation, Heterologous; Vinblastine | 1982 |
Induced and inherent resistance to alkylating agents in human small-cell bronchial carcinoma xenografts.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Carcinoma, Small Cell; Cyclophosphamide; Drug Resistance; Female; Humans; Lung Neoplasms; Melphalan; Mice; Mice, Inbred CBA; Semustine; Time Factors; Vincristine | 1984 |
Studies on drug resistance in a human melanoma xenograft system.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dacarbazine; Disease Models, Animal; DNA; Drug Resistance; Humans; Ifosfamide; Kinetics; Melanoma; Melphalan; Mice; Mice, Nude; Neoplasm Transplantation; Semustine; Transplantation, Heterologous | 1984 |
Use of the agar diffusion chamber for the exposure of human tumor cells to drugs.
Topics: Agar; Animals; Antineoplastic Agents; Cell Survival; Diffusion; Doxorubicin; Drug Evaluation, Preclinical; Humans; Melanoma; Melphalan; Mice; Neoplasm Transplantation; Semustine; Transplantation, Heterologous | 1982 |
In vitro chemosensitivity tests on xenografted human melanomas.
Topics: Animals; Antineoplastic Agents; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Male; Melanoma; Melphalan; Mice; Neoplasm Transplantation; Semustine; Transplantation, Heterologous | 1980 |
Enhancement of antitumor activity of alkylating agents by the radiation sensitizer misonidazole.
Topics: Alkylating Agents; Animals; Aziridines; Benzoquinones; Cyclohexenes; Cyclophosphamide; Drug Therapy, Combination; Female; Melphalan; Mice; Misonidazole; Neoplasms, Experimental; Nitroimidazoles; Quinones; Semustine | 1980 |
[MMC conditioning regimen (Melphalan, MeCCNU and cyclophosphamide) followed by allogeneic peripheral blood stem cells transplantation for chronic myeloid leukemia].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Melphalan; Semustine; Transplantation Conditioning | 1998 |
[The introduction of preoperative staging laparoscopy and molecular diagnosis of peritoneal lavages for the treatment of advanced gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cyclophosphamide; Humans; Infusions, Parenteral; Laparoscopy; Melphalan; Neoplasm Staging; Peritoneal Lavage; Prognosis; Semustine; Stomach Neoplasms | 2002 |
FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cell Death; China; Cyclophosphamide; Fas Ligand Protein; Female; Flow Cytometry; Genetic Predisposition to Disease; Genotype; Haplotypes; HeLa Cells; Humans; Interleukin-2; Leukocytes, Mononuclear; Linkage Disequilibrium; Melphalan; Membrane Glycoproteins; Middle Aged; Polymorphism, Genetic; Risk Factors; Semustine; T-Lymphocytes; Tumor Necrosis Factors; Uterine Cervical Neoplasms | 2005 |
[Comparison of the long term results between two conditioning regimens MCC and BuCy in chronic myelocytic leukemia after allogeneic stem cell transplantation].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Melphalan; Middle Aged; Semustine; Stem Cell Transplantation; Treatment Outcome | 2006 |
Chemoradiotherapy in patients with anal cancer: impact of length of unplanned treatment interruption on outcome.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Cyclophosphamide; Dose Fractionation, Radiation; Female; Fluorouracil; Humans; Male; Melphalan; Middle Aged; Radiotherapy Dosage; Retrospective Studies; Semustine; Time Factors; Treatment Outcome | 2006 |
Modified BuCy is an alternative conditioning regimen for lymphoma patients undergoing autologous stem cell transplantation.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Autografts; Busulfan; Cyclophosphamide; Cytarabine; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Melphalan; Middle Aged; Semustine; Survival Rate; Transplantation Conditioning | 2019 |
Efficacy and toxicity of SEAM (semustine, etoposide, cytarabine, and melphalan) conditioning regimen followed by autologous stem cell transplantation in lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Melphalan; Retrospective Studies; Semustine; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Autologous | 2022 |